Results 261 to 270 of about 180,104 (298)

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS

2006
J. Roman-Rodriguez, C.M. Hart, S.W. Han
openaire   +2 more sources

Peroxisome Proliferator-Activated Receptors

2012
Julien S. Baker, Fergal Grace, Lon Kilgore, David J. Smith, Stephen R. Norris, Andrew W. Gardner, Robert Ringseis, Klaus Eder, Roy J. Shephard, Peter Kokkinos, Rebecca E. Lee, Angela Ho, Goran Markovic, Brian R. MacIntosh, Frans Nollet, Ruben Barakat, Marlene N. Silva, Pedro J. Teixeira, Peter Hassmén, Hans Christian Haverkamp, Hans Christian Haverkamp   +20 more
openaire   +2 more sources

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Peroxisome Proliferator-Activated Receptors

2013
Jihan A. Youssef, Mostafa Z. Badr
openaire   +2 more sources

Peroxisome Proliferator-Activated Receptors

2010
J.P. Vanden Heuvel, J.M. Peters
openaire   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Peroxisome Proliferator-Activated Receptors

2008
Jane A. Pinaire, Anne Reifel-Miller
openaire   +2 more sources